![](https://flagship-pioneering.transforms.svdcdn.com/production/newcos/Still-for-Gen-AI.jpg?w=300&h=300&auto=compress%2Cformat&fit=crop&dm=1704995887&s=e2e5f43ad4374682c5c628ef774fb5b4)
Montai Therapeutics
Montai Therapeutics is pioneering the creation of Anthromolecule™ medicines – unlocked from a privileged class of molecules with a history of safe, human consumption — to treat and preempt chronic disease. Montai’s CONECTA™ platform comprehensively maps Anthromolecule bioactivity across pathways that drive disease. The CONECTA platform leverages rapid and ever-growing advancements in the digitization of natural chemistry and human biology coupled with powerful computational tools for linking chemical structure and bioactivity. This confluence of biotechnologies enables Montai to build a powerful, one-of-a-kind discovery platform focused on creating safe, effective, and more human-centric medicines than ever before.